FDA Committee Recommends Approval of Mylotarg to Treat Newly Diagnosed AML
News
The Oncologic Drug Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) supports the approval of Pfizer’s Mylotarg (gemtuzumab ozogamicin), in combination with standard chemotherapy, for the treatment ... Read more